Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Rankning i aktier #33687
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Aktiekurs
$4.70
Senast synkroniserad: 2026-08-14
Marknadsvärde
$7.09M
Förändring (1 dag)
-0.21%
Förändring (1 år)
-70.63%
Land
US
Handel Apimeds Pharmaceuticals US, Inc (APUS)

Kategori

Historik för aktiesplit för Apimeds Pharmaceuticals US, Inc (APUS)
Aktien Apimeds Pharmaceuticals US, Inc (symbol: APUS) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 17, 2026.
En APUS-aktie köpt före Aug 17, 2026 motsvarar nu 0 APUS-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE